arylalkylamine vanadium salts (Genmedica)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namearylalkylamine vanadium salts (Genmedica)
Drug Alias NameB5V10 seriesB4V10 seriesB6V10 series
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin receptor agonistsGlucose transporter 1 stimulants
TargetsGlucose transporter 1Insulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenmedica Therapeutics Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenmedica Therapeutics Sl
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A